Cohance Lifesciences To Sell Hyderabad Clinical Research Unit For ₹160 Million

Cohance Lifesciences Ltd. on Friday said it will divest assets of its standalone clinical research and bio-analytical unit in Hyderabad to Chromo Laboratories Inda Pvt. Ltd. for ₹160 million.

The company called the unit a non-core legacy asset with limited alignment to its core CDMO operations. The sale is expected to close in the September quarter.